Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
People's Hospital of Xinjiang Uygur Autonomous Region
Institut Claudius Regaud
Ohio State University Comprehensive Cancer Center
The Methodist Hospital Research Institute
Montefiore Medical Center
Gustave Roussy, Cancer Campus, Grand Paris
M.D. Anderson Cancer Center
Affiliated Hospital of Nantong University
Brown University
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Shanxi Province Cancer Hospital
The Christie NHS Foundation Trust
Faculty of Medicine of Tunis
Duke University
Roswell Park Cancer Institute
Centre Oscar Lambret
Centre Oscar Lambret
University of Kentucky
Emory University
Institut Bergonié
Institute of Oncology Ljubljana
University Health Network, Toronto
Abramson Cancer Center at Penn Medicine
The Netherlands Cancer Institute
University of Nebraska
Tianjin Medical University Cancer Institute and Hospital
Medical University of South Carolina
Memorial Sloan Kettering Cancer Center
Yonsei University
University of Vermont
Columbia University
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Big Ten Cancer Research Consortium
Big Ten Cancer Research Consortium
Ezisurg Medical Co. Ltd.
Rigshospitalet, Denmark
Anhui Medical University
Samsung Medical Center
Centre Henri Becquerel
Centre Henri Becquerel
Centre Henri Becquerel
Seoul National University Hospital